Tumor-infiltrating Leukocytes Suppress Local Inflammation Via Interleukin-1 Receptor Antagonist in a Syngeneic Prostate Cancer Model
Background: Several lines of evidence have demonstrated the tumor-promoting function of inflammation. Since many chemokines are important in coordinating immune cells during inflammation, monitoring intratumoral chemokines provides a way to study the tumor microenvironment. Methods: To identify tumo...
Main Authors: | Yu-Ching Fan, Wei-Yu Chen, Kuan-Der Lee, Yuan-Chin Tsai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/9/4/67 |
Similar Items
-
Roles of Interleukin-1 Receptor Antagonist in Prostate Cancer Progression
by: Yu-Ching Fan, et al.
Published: (2020-12-01) -
Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer
by: Yu-Ching Fan, et al.
Published: (2023-08-01) -
Interleukin-1 receptor antagonist: a promising cytokine against human squamous cell carcinomas
by: Yujie Ding, et al.
Published: (2023-04-01) -
Tumor-Associated Lymphatics Upregulate MHC-II to Suppress Tumor-Infiltrating Lymphocytes
by: Claire Y. Li, et al.
Published: (2022-11-01) -
Perivascular Tumor-Infiltrating Leukocyte Scoring for Prognosis of Resected Hepatocellular Carcinoma Patients
by: Markus Bo Schoenberg, et al.
Published: (2018-10-01)